News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 16, 2020, 06:00 ET United Therapeutics Corporation to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairman and Chief Executive Officer of United...


Sep 11, 2020, 06:00 ET United Therapeutics Corporation Appoints Linda Maxwell to Its Board of Directors

United Therapeutics Corporation (Nasdaq: UTHR) announced today the appointment of Linda Maxwell, M.D. to its Board of Directors as an independent...


Aug 17, 2020, 06:00 ET United Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung Disease

United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) accepted for review the supplemental...


Aug 05, 2020, 06:00 ET United Therapeutics Corporation to Present at the Wedbush PacGrow Healthcare Virtual Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairman and Chief Executive Officer of United...


Jul 29, 2020, 06:00 ET United Therapeutics Corporation Reports Second Quarter 2020 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended June 30, 2020. "I am pleased with our...


Jul 23, 2020, 06:00 ET United Therapeutics Corporation Asserts New Tyvaso Patent Against Liquidia

United Therapeutics Corporation (Nasdaq: UTHR) announced today the United States Patent and Trademark Office issued a new patent on July 21, 2020,...


Jul 22, 2020, 06:00 ET United Therapeutics Corporation To Report Second Quarter 2020 Financial Results Before The Market Opens On Wednesday, July 29, 2020

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its second quarter 2020 financial results before the market opens...


Jun 17, 2020, 06:00 ET United Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual Session

United Therapeutics Corporation (Nasdaq: UTHR) announced today that key data from the INCREASE study of Tyvaso® (treprostinil) Inhalation Solution in ...


Jun 05, 2020, 06:00 ET United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has filed a lawsuit in the U.S. District Court for the District of Delaware...


May 26, 2020, 06:00 ET United Therapeutics Corporation to Present at the Jefferies Virtual Health Care Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Mr. James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, ...


May 06, 2020, 06:00 ET United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Mr. James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, ...


Apr 29, 2020, 06:00 ET United Therapeutics Corporation Reports First Quarter 2020 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31, 2020. First quarter net revenue...


Apr 23, 2020, 06:00 ET United Therapeutics Announces Additional Results From FREEDOM-EV Study Showing The Hemodynamic And Risk Status Reduction Benefits Of Orenitram Treatment In Patients With Pulmonary Arterial Hypertension

United Therapeutics Corporation (Nasdaq: UTHR) today detailed recent publications on Orenitram® (treprostinil) Extended-Release Tablets, which...


Apr 22, 2020, 06:00 ET United Therapeutics Corporation to Report First Quarter 2020 Financial Results Before the Market Opens on Wednesday, April 29, 2020

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2020 financial results before the market opens...


Feb 26, 2020, 06:00 ET United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2019. Full...


Feb 25, 2020, 06:00 ET United Therapeutics Corporation To Present At The 40th Annual Cowen And Company Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Michael Benkowitz, President and Chief Operating Officer of United Therapeutics,...


Feb 24, 2020, 06:16 ET United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®

United Therapeutics Corporation (Nasdaq: UTHR) and DEKA Research & Development Corp. today announced receipt of an additional 510(k) clearance by the ...


Feb 24, 2020, 06:00 ET United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints

United Therapeutics Corporation (NASDAQ: UTHR) today announced that preliminary analysis indicates that the INCREASE clinical study of Tyvaso®...


Feb 19, 2020, 06:00 ET United Therapeutics Corporation to Report Fourth Quarter and Full Year 2019 Financial Results Before the Market Opens on Wednesday, February 26, 2020

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its fourth quarter and full year 2019 financial results before the ...


Feb 04, 2020, 17:00 ET United Therapeutics Defeats Preliminary Injunction Motion In Litigation With Sandoz And RareGen

United Therapeutics Corporation (Nasdaq: UTHR) announced that on January 29, 2020, the United States District Court for the District of New Jersey...


Feb 03, 2020, 06:00 ET United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint

United Therapeutics Corporation (Nasdaq: UTHR) today announced topline results from the phase 2/3 DISTINCT clinical study evaluating Unituxin®...


Jan 06, 2020, 06:00 ET United Therapeutics Corporation To Present At The 38th Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United...


Oct 30, 2019, 06:00 ET United Therapeutics Corporation Reports Third Quarter 2019 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended September 30, 2019. "We are pleased to see ...


Oct 23, 2019, 06:00 ET United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2019 financial results before the market opens...


Oct 21, 2019, 06:00 ET United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study

United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplement to the New...